Onrigin laromustine regulatory update

Vion received a complete response letter from the FDA for an NDA for Onrigin

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE